1. Home
  2. ALKS vs GLOB Comparison

ALKS vs GLOB Comparison

Compare ALKS & GLOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALKS
  • GLOB
  • Stock Information
  • Founded
  • ALKS 1987
  • GLOB 2003
  • Country
  • ALKS Ireland
  • GLOB Luxembourg
  • Employees
  • ALKS N/A
  • GLOB N/A
  • Industry
  • ALKS Biotechnology: Pharmaceutical Preparations
  • GLOB EDP Services
  • Sector
  • ALKS Health Care
  • GLOB Technology
  • Exchange
  • ALKS Nasdaq
  • GLOB Nasdaq
  • Market Cap
  • ALKS 4.9B
  • GLOB 4.7B
  • IPO Year
  • ALKS 1991
  • GLOB 2014
  • Fundamental
  • Price
  • ALKS $27.87
  • GLOB $56.34
  • Analyst Decision
  • ALKS Strong Buy
  • GLOB Buy
  • Analyst Count
  • ALKS 14
  • GLOB 14
  • Target Price
  • ALKS $41.29
  • GLOB $138.71
  • AVG Volume (30 Days)
  • ALKS 1.9M
  • GLOB 1.4M
  • Earning Date
  • ALKS 10-23-2025
  • GLOB 11-13-2025
  • Dividend Yield
  • ALKS N/A
  • GLOB N/A
  • EPS Growth
  • ALKS 21.99
  • GLOB N/A
  • EPS
  • ALKS 2.08
  • GLOB 2.44
  • Revenue
  • ALKS $1,505,296,000.00
  • GLOB $2,482,415,000.00
  • Revenue This Year
  • ALKS N/A
  • GLOB $3.90
  • Revenue Next Year
  • ALKS $1.66
  • GLOB $4.14
  • P/E Ratio
  • ALKS $13.19
  • GLOB $23.24
  • Revenue Growth
  • ALKS N/A
  • GLOB 8.66
  • 52 Week Low
  • ALKS $25.17
  • GLOB $54.36
  • 52 Week High
  • ALKS $36.45
  • GLOB $238.32
  • Technical
  • Relative Strength Index (RSI)
  • ALKS 48.33
  • GLOB 27.57
  • Support Level
  • ALKS $26.40
  • GLOB $54.36
  • Resistance Level
  • ALKS $28.65
  • GLOB $59.00
  • Average True Range (ATR)
  • ALKS 1.13
  • GLOB 2.37
  • MACD
  • ALKS -0.20
  • GLOB -0.07
  • Stochastic Oscillator
  • ALKS 41.41
  • GLOB 13.94

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About GLOB Globant S.A.

Globant is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2003 in Argentina but is currently headquartered in Luxembourg and primarily serves clients in the US and Latin America. Globant's client base is relatively concentrated in the media and entertainment and financial services industries.

Share on Social Networks: